Literature DB >> 17327211

History of protein crystallography in China.

Zihe Rao1.   

Abstract

China has a strong background in X-ray crystallography dating back to the 1920s. Protein crystallography research in China was first developed following the successful synthesis of insulin in China in 1966. The subsequent determination of the three-dimensional structure of porcine insulin made China one of the few countries which could determine macromolecular structures by X-ray diffraction methods in the late 1960s and early 1970s. After a slow period during the 1970s and 1980s, protein crystallography in China has reached a new climax with a number of outstanding accomplishments. Here, I review the history and progress of protein crystallography in China and detail some of the recent research highlights, including the crystal structures of two membrane proteins as well as the structural genomics initiative in China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327211      PMCID: PMC2435569          DOI: 10.1098/rstb.2007.2032

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  17 in total

1.  An overview of structural genomics.

Authors:  S K Burley
Journal:  Nat Struct Biol       Date:  2000-11

Review 2.  Timeline: the march of structural biology.

Authors:  Iain D Campbell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

3.  Crystal structure of spinach major light-harvesting complex at 2.72 A resolution.

Authors:  Zhenfeng Liu; Hanchi Yan; Kebin Wang; Tingyun Kuang; Jiping Zhang; Lulu Gui; Xiaomin An; Wenrui Chang
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

Review 4.  Shining a light on structural genomics.

Authors:  S H Kim
Journal:  Nat Struct Biol       Date:  1998-08

5.  Homology of trichosanthin and ricin A chain.

Authors:  X J Zhang; J H Wang
Journal:  Nature       Date:  1986 May 29-Jun 4       Impact factor: 49.962

6.  Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.

Authors:  Yanhui Xu; Jieqing Zhu; Yiwei Liu; Zhiyong Lou; Fang Yuan; Yueyong Liu; David K Cole; Ling Ni; Nan Su; Lan Qin; Xu Li; Zhihong Bai; John I Bell; Hai Pang; Po Tien; George F Gao; Zihe Rao
Journal:  Biochemistry       Date:  2004-11-09       Impact factor: 3.162

7.  Crystal structure of human tryptophanyl-tRNA synthetase catalytic fragment: insights into substrate recognition, tRNA binding, and angiogenesis activity.

Authors:  Yadong Yu; Yunqing Liu; Ning Shen; Xiang Xu; Feng Xu; Jie Jia; Youxin Jin; Eddy Arnold; Jianping Ding
Journal:  J Biol Chem       Date:  2003-12-05       Impact factor: 5.157

8.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.

Authors:  Haitao Yang; Maojun Yang; Yi Ding; Yiwei Liu; Zhiyong Lou; Zhe Zhou; Lei Sun; Lijuan Mo; Sheng Ye; Hai Pang; George F Gao; Kanchan Anand; Mark Bartlam; Rolf Hilgenfeld; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

9.  Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer.

Authors:  Yujia Zhai; Fei Sun; Xuemei Li; Hai Pang; Xiaoling Xu; Mark Bartlam; Zihe Rao
Journal:  Nat Struct Mol Biol       Date:  2005-11       Impact factor: 15.369

10.  Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core.

Authors:  Yanhui Xu; Yiwei Liu; Zhiyong Lou; Lan Qin; Xu Li; Zhihong Bai; Hai Pang; Po Tien; George F Gao; Zihe Rao
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  1 in total

1.  Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.

Authors:  Daniel F Berenson; Allison R Weiss; Zhu-Li Wan; Michael A Weiss
Journal:  Ann N Y Acad Sci       Date:  2012-03-13       Impact factor: 5.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.